Cargando…

Mucosa-Associated Lymphoid Tissue Lymphoma of the Larynx

BACKGROUND: Mucosa-associated lymphoid tissue (MALT) lymphomas are a subtype of non-Hodgkin lymphoma stemming from marginal zone B-cells. In this case report, we present two patients with an extremely rare localization of MALT lymphoma to the larynx. METHODS: Case 1 is of a 78-year-old male presenti...

Descripción completa

Detalles Bibliográficos
Autores principales: Rizvi, Omar, Nielsen, Tyson, Bearelly, Shethal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7450344/
https://www.ncbi.nlm.nih.gov/pubmed/32908756
http://dx.doi.org/10.1155/2020/8703921
_version_ 1783574799117713408
author Rizvi, Omar
Nielsen, Tyson
Bearelly, Shethal
author_facet Rizvi, Omar
Nielsen, Tyson
Bearelly, Shethal
author_sort Rizvi, Omar
collection PubMed
description BACKGROUND: Mucosa-associated lymphoid tissue (MALT) lymphomas are a subtype of non-Hodgkin lymphoma stemming from marginal zone B-cells. In this case report, we present two patients with an extremely rare localization of MALT lymphoma to the larynx. METHODS: Case 1 is of a 78-year-old male presenting with a six-month history of progressive hoarseness with a past medical history significant for marginal zone lymphoma of the right orbit. Diagnosis was confirmed with a biopsy for extranodal marginal zone B-cell lymphoma of MALT type. An FDG-PET scan was done but did not show any sign of FDG avid malignancy, including at the primary site. Case 2 is a 60-year-old female presenting with one year of worsening throat discomfort, intermittent cough, and dyspnea with exertion. Pathology confirmed a diagnosis of extranodal marginal zone B-cell lymphoma of MALT type. RESULTS: Case 1 was treated with low-dose radiation at 4 Gy delivered over two fractions of 2 Gy each. Upon completion of radiation treatment, he reported a resolution of his hoarseness and normalization of his voice. A four-month follow-up in May 2018 with flexible nasolaryngoscopy revealed a normal exam with fully mobile vocal folds bilaterally and no evidence of left false vocal fold submucosal mass. At seven months following treatment, the patient died unexpectedly of unknown causes. Case 2 was treated with radiation at 30 Gy in 15 fractions over the course of one month. Following completion of radiation therapy, she had improvement of her sore throat, nausea, dysphagia, dysgeusia, and dry mouth. At 21-month follow-up, she had no evidence of disease. CONCLUSION: This case report demonstrates that MALT lymphoma can present with much more benign and subtle symptoms. This highlights the importance of clinicians to keep broad differentials and consider MALT lymphomas in the setting of laryngeal masses.
format Online
Article
Text
id pubmed-7450344
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-74503442020-09-08 Mucosa-Associated Lymphoid Tissue Lymphoma of the Larynx Rizvi, Omar Nielsen, Tyson Bearelly, Shethal Case Rep Otolaryngol Case Report BACKGROUND: Mucosa-associated lymphoid tissue (MALT) lymphomas are a subtype of non-Hodgkin lymphoma stemming from marginal zone B-cells. In this case report, we present two patients with an extremely rare localization of MALT lymphoma to the larynx. METHODS: Case 1 is of a 78-year-old male presenting with a six-month history of progressive hoarseness with a past medical history significant for marginal zone lymphoma of the right orbit. Diagnosis was confirmed with a biopsy for extranodal marginal zone B-cell lymphoma of MALT type. An FDG-PET scan was done but did not show any sign of FDG avid malignancy, including at the primary site. Case 2 is a 60-year-old female presenting with one year of worsening throat discomfort, intermittent cough, and dyspnea with exertion. Pathology confirmed a diagnosis of extranodal marginal zone B-cell lymphoma of MALT type. RESULTS: Case 1 was treated with low-dose radiation at 4 Gy delivered over two fractions of 2 Gy each. Upon completion of radiation treatment, he reported a resolution of his hoarseness and normalization of his voice. A four-month follow-up in May 2018 with flexible nasolaryngoscopy revealed a normal exam with fully mobile vocal folds bilaterally and no evidence of left false vocal fold submucosal mass. At seven months following treatment, the patient died unexpectedly of unknown causes. Case 2 was treated with radiation at 30 Gy in 15 fractions over the course of one month. Following completion of radiation therapy, she had improvement of her sore throat, nausea, dysphagia, dysgeusia, and dry mouth. At 21-month follow-up, she had no evidence of disease. CONCLUSION: This case report demonstrates that MALT lymphoma can present with much more benign and subtle symptoms. This highlights the importance of clinicians to keep broad differentials and consider MALT lymphomas in the setting of laryngeal masses. Hindawi 2020-08-18 /pmc/articles/PMC7450344/ /pubmed/32908756 http://dx.doi.org/10.1155/2020/8703921 Text en Copyright © 2020 Omar Rizvi et al. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Rizvi, Omar
Nielsen, Tyson
Bearelly, Shethal
Mucosa-Associated Lymphoid Tissue Lymphoma of the Larynx
title Mucosa-Associated Lymphoid Tissue Lymphoma of the Larynx
title_full Mucosa-Associated Lymphoid Tissue Lymphoma of the Larynx
title_fullStr Mucosa-Associated Lymphoid Tissue Lymphoma of the Larynx
title_full_unstemmed Mucosa-Associated Lymphoid Tissue Lymphoma of the Larynx
title_short Mucosa-Associated Lymphoid Tissue Lymphoma of the Larynx
title_sort mucosa-associated lymphoid tissue lymphoma of the larynx
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7450344/
https://www.ncbi.nlm.nih.gov/pubmed/32908756
http://dx.doi.org/10.1155/2020/8703921
work_keys_str_mv AT rizviomar mucosaassociatedlymphoidtissuelymphomaofthelarynx
AT nielsentyson mucosaassociatedlymphoidtissuelymphomaofthelarynx
AT bearellyshethal mucosaassociatedlymphoidtissuelymphomaofthelarynx